文献速递妇科

子宫颈癌根治性子宫切除术在腹腔镜宫颈癌入路试验后的术式选择及相关并发症:一项国家手术质量改进计划研究

Approach to radical hysterectomy for cervical cancer after the Laparoscopic Approach to Cervical Cancer trial and associated complications: a National Surgical Quality Improvement Program study.
PubMed 文献 · Am J Obstet Gynecol · 2024-08-14

该研究利用国家手术质量改进计划登记数据,分析2012至2022年间因宫颈癌行根治性子宫切除术的3611例患者。腹腔镜宫颈癌入路试验2018年发表后,微创手术比例从2018年50.4%降至2022年11.4%(P<.001),但主要并发症发生率在试验前后无显著差异(7.4% vs 5.8%,P=.26)。多因素分析显示手术入路与主要并发症无独立关联(校正OR 1.02,95%CI 0.63-1.65)。

要点

  • 腹腔镜宫颈癌入路试验发表后,微创根治性子宫切除术比例从2018年50.4%降至2022年11.4%(P<.001)。
  • 试验前后主要并发症发生率无显著差异(7.4% vs 5.8%,P=.26)。
  • 手术入路与主要并发症无独立关联(校正OR 1.02,95%CI 0.63-1.65)。

核心结论

  • 尽管腹腔镜宫颈癌入路试验后微创根治性子宫切除术比例急剧下降,但术后主要并发症发生率无变化。
  • 根治性子宫切除术的手术入路与主要术后并发症无关联。

研究设计与样本

  • 使用国家手术质量改进计划登记数据,分析2012至2022年间因宫颈癌行根治性子宫切除术的3611例患者。
  • 排除阴道根治性子宫切除术和单纯子宫切除术。
  • 按腹腔镜宫颈癌入路试验2018年发表前后分层(2012-2017年 vs 2019-2022年),比较手术入路趋势和手术并发症率。

主要发现

  • 3611例患者中,2080例(57.6%)行开腹手术,1531例(42.4%)行微创根治性子宫切除术。
  • 微创手术比例从2012年45.6%显著增至2017年75.3%(P<.01),从2018年50.4%显著降至2022年11.4%(P<.001)。
  • 试验前轻度并发症率低于试验后(317例[16.9%] vs 288例[21.3%],P=.002),主要并发症率相似(139例[7.4%] vs 78例[5.8%],P=.26)。
  • 试验前输血率低于试验后(137例[7.3%] vs 133例[9.8%],P=.012),浅表手术部位感染率也较低(20例[1.1%] vs 53例[3.9%],P<.001)。
  • 整个研究期间,微创组轻度并发症率低于开腹组(190例[12.4%] vs 472例[22.7%],P<.001),主要并发症率相似(100例[6.5%] vs 139例[6.7%],P=.89)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Laparoscopic Approach to Cervical Cancer study results revolutionized our understanding of the best surgical management for this disease. After its publication, the guidelines state that the standard and recommended approach for radical hysterectomy is an open abdominal approach. Nevertheless, the effect of the Laparoscopic Approach to Cervical Cancer trial on real-world changes in the surgical approach to radical hysterectomy remains elusive. OBJECTIVE: This study aimed to investigate the trends and routes of radical hysterectomy and to evaluate postoperative complication rates before and after the Laparoscopic Approach to Cervical Cancer trial (2018). STUDY DESIGN: The National Surgical Quality Improvement Program registry was used to examine radical hysterectomy for cervical cancer performed between 2012 and 2022. This study excluded vaginal radical hysterectomies and simple hysterectomies. The primary outcome measures were the trends in the route of surgery (minimally invasive surgery vs laparotomy) and surgical complication rates, stratified by periods before and after the publication of the Laparoscopic Approach to Cervical Cancer trial in 2018 (2012-2017 vs 2019-2022). The secondary outcome measure was major complications associated specifically with the different routes of surgery. RESULTS: Of the 3611 patients included, 2080 (57.6%) underwent laparotomy, and 1531 (42.4%) underwent minimally invasive radical hysterectomy. There was a significant increase in the minimally invasive surgery approach from 2012 to 2017 (45.6% in minimally invasive surgery in 2012 to 75.3% in minimally invasive surgery in 2017; P<.01) and a significant decrease in minimally invasive surgery from 2018 to 2022 (50.4% in minimally invasive surgery in 2018 to 11.4% in minimally invasive surgery in 2022; P<.001). The rate of minor complications was lower in the period before the Laparoscopic Approach to Cervical Cancer trial than after the trial (317 [16.9%] vs 288 [21.3%], respectively; P=.002). The major complication rates were similar before and after the Laparoscopic Approach to Cervical Cancer trial (139 [7.4%] vs 78 [5.8%], respectively; P=.26). The rates of blood transfusions and superficial surgical site infections were lower in the period before the Laparoscopic Approach to Cervical Cancer trial than in the period after the trial (137 [7.3%] vs 133 [9.8%] [P=.012] and 20 [1.1%] vs 53 [3.9%] [P<.001], respectively). In a comparison of minimally invasive surgery vs laparotomy radical hysterectomy during the entire study period, patients in the minimally invasive surgery group had lower rates of minor complications than in those in the laparotomy group (190 [12.4%] vs 472 [22.7%], respectively; P<.001), and the rates of major complications were similar in both groups (100 [6.5%] in the minimally invasive surgery group vs 139 [6.7%] in the laparotomy group; P=.89). In a specific complications analysis, the rates of blood transfusion and superficial surgical site infections were lower in the minimally invasive surgery group than in the laparotomy group (2.4% vs 12.7% and 0.6% vs 3.4%, respectively; P<.001; for both comparisons), and the rate of deep incisional surgical site infections was lower in the minimally invasive surgery group than in the laparotomy group (0.2% vs 0.7%, respectively; P=.048). In the multiple logistic regression analysis, the route of radical hysterectomy was not independently associated with the occurrence of major complications (adjusted odds ratio, 1.02; 95% confidence interval, 0.63-1.65). CONCLUSION: Although the proportion of minimally invasive radical hysterectomies decreased abruptly after the Laparoscopic Approach to Cervical Cancer trial, there was no change in the rate of major postoperative complications. In addition, the hysterectomy route was not associated with major postoperative complications.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Levin G, Ramirez PT, Wright JD, et al. Approach to radical hysterectomy for cervical cancer after the Laparoscopic Approach to Cervical Cancer trial and associated complications: a National Surgical Quality Improvement Program study. Am J Obstet Gynecol. 2024. PMID: 39151769. doi:10.1016/j.ajog.2024.08.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。